PVpharm starts a new collaboration with the International AIDS Vaccine Initiative (IAVI)

PVpharm starts a new collaboration with the International AIDS Vaccine Initiative (IAVI)

  • Post published:May 22, 2023

We are so excited to announce the new collaboration agreement signed by our company with the International AIDS Vaccine Initiative (IAVI) to provide pharmacovigilance and regulatory consulting. IAVI is a nonprofit scientific research organization that develops vaccines and antibodies for HIV, tuberculosis, emerging infectious diseases (including COVID-19), and other neglected diseases, with a clear commitment to develop affordable and accesible solutions to these diseases. In the same way as our collaboration with the Leiden University Medical Center (LUMC) or with the Center for Human Drug Research (CHDR), PVpharm works to provide pharmacovigilance support in pre-approval phases of the development of innovative drugs. In this agreement, we…

Continue ReadingPVpharm starts a new collaboration with the International AIDS Vaccine Initiative (IAVI)
Online EVWeb training 22-26 May 2023

Online EVWeb training 22-26 May 2023

  • Post published:May 17, 2023

Isabella Pallagiano from PVpharm will be participating as a trainer, together with Calin Lungu and Vojtech Kvita in the next EVWeb training on 22-26 May 2023. The training will be delivered online in the morning time (9:00-13:30 CEST). The training is targeted to: -Users who have to report and analyse suspected adverse reactions in the pre- and post-authorisation phase using the ISO/ICH E2B(R3) ICSR format-Users of EudraVigilance – new users and users already trained on working with EudraVigilance-Professionals performing electronic transmission of ICSRs, who operate as Gateway traders or as WebTrader (i.e., who use EVWEB or EV Post)-Sponsors of Clinical…

Continue ReadingOnline EVWeb training 22-26 May 2023
We are in the press! El Economista

We are in the press! El Economista

  • Post published:May 9, 2023

PVpharm is in "El Economista" on 9th May 2023, the news diary published an article about PVpharm; where our CEO, José Alberto Ayala Ortiz, introduces our company, explains what pharmacovigilance is and how does PVpharm deal with different regulations. PVpharm is a global reference in Pharmacovigilance: https://www.eleconomista.es/branded-content/noticias/12258631/05/23/jose-alberto-ayala-ortiz-pvpharm-somos-una-referencia-global-en-el-campo-de-la-farmacovigilancia.html You can follow us on LinkedIn and learn more about us clicking here.

Continue ReadingWe are in the press! El Economista
PVpharm initiates a collaboration with the Leiden University Medical Center (LUMC) in the Netherlands

PVpharm initiates a collaboration with the Leiden University Medical Center (LUMC) in the Netherlands

  • Post published:May 3, 2023

We are happy to announce that PVpharm have enter in a new agreement with Leiden University Medical Center (LUMC) to provide safety and regulatory consulting. LUMC was formed from a collaboration between the Academic Hospital Leiden and the Faculty of Medicine of Leiden University, and provides scientific and material support to first steps of the drug development in humans. As an innovator, the LUMC stands for improving healthcare and people's health. This is done on the basis of leading research and innovative education. The objective of the LUMC is to be one of the top 10 University Medical Centers in…

Continue ReadingPVpharm initiates a collaboration with the Leiden University Medical Center (LUMC) in the Netherlands